MEG
ZBH icon

Millstone Evans Group’s Zimmer Biomet ZBH Stock Holding History

Millstone Evans Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Buy
160
+80
+100% +$7.01K 0.01% 553
2026
Q1 		$7.23K Hold
80
– – ﹤0.01% 609
2025
Q4 		$7.19K Hold
80
– – ﹤0.01% 597
2025
Q3 		$7.88K Sell
80
-34
-30% -$3.37K 0.01% 565
2025
Q2 		$10.4K Hold
114
– – 0.01% 520
2025
Q1 		$12.9K Hold
114
– – 0.01% 498
2024
Q4 		$12K Buy
+114
New +$12.2K 0.01% 477

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Millstone Evans Group's ZBH Position: Q2 2026 in Review

Millstone Evans Group increased its Zimmer Biomet (ZBH) stake by 100% in Q2 2026, buying an estimated $7.01K and bringing the position to 160 shares worth $13.8K. The position accounts for 0.01% of the portfolio, ranked #553.

Millstone Evans Group first reported a position in ZBH in Q4 2024 and has held it in 7 quarters since. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Millstone Evans Group held 160 shares of Zimmer Biomet worth $13.8K as of Q2 2026.
  • Millstone Evans Group bought 80 Zimmer Biomet shares in Q2 2026, an estimated $7.01K.
  • Zimmer Biomet made up 0.01% of Millstone Evans Group's portfolio in Q2 2026, its #553 holding.
  • Millstone Evans Group first reported a position in Zimmer Biomet in Q4 2024 and has held it in 7 quarters since.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.